Trish K. Lankford

682 total citations
18 papers, 592 citations indexed

About

Trish K. Lankford is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Molecular Biology. According to data from OpenAlex, Trish K. Lankford has authored 18 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Immunology and Allergy and 9 papers in Molecular Biology. Recurrent topics in Trish K. Lankford's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Cell Adhesion Molecules Research (10 papers) and Glycosylation and Glycoproteins Research (7 papers). Trish K. Lankford is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Cell Adhesion Molecules Research (10 papers) and Glycosylation and Glycoproteins Research (7 papers). Trish K. Lankford collaborates with scholars based in United States and Japan. Trish K. Lankford's co-authors include Stephen J. Kennel, Linda J. Foote, Gregory B. Hurst, S G Shinpock, Claude D. Stringer, Saed Mirzadeh, Anthony Makkinje, Virginia Godfrey, Martin W. Brechbiel and Lara L. Chappell and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Cell Science and BioScience.

In The Last Decade

Trish K. Lankford

18 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trish K. Lankford United States 12 268 266 172 125 83 18 592
Michela Silacci Switzerland 11 379 1.4× 358 1.3× 163 0.9× 46 0.4× 179 2.2× 13 702
Timothy J. Dudgeon United Kingdom 9 133 0.5× 273 1.0× 196 1.1× 55 0.4× 77 0.9× 10 469
Marlene Tacke Germany 10 101 0.4× 237 0.9× 48 0.3× 84 0.7× 133 1.6× 11 598
Ignacio Gonzales-Gomez United States 8 257 1.0× 243 0.9× 218 1.3× 41 0.3× 139 1.7× 11 656
Alexander Zheleznyak United States 16 309 1.2× 352 1.3× 153 0.9× 102 0.8× 298 3.6× 26 945
Thomas Schürpf United States 10 93 0.3× 230 0.9× 189 1.1× 87 0.7× 133 1.6× 13 502
Steven J. Lahr United States 8 180 0.7× 367 1.4× 278 1.6× 33 0.3× 46 0.6× 11 860
Jascha‐N. Rybak Switzerland 6 209 0.8× 276 1.0× 81 0.5× 94 0.8× 143 1.7× 7 550
Eckart Planker Germany 5 202 0.8× 690 2.6× 416 2.4× 62 0.5× 238 2.9× 8 981
Laura Giuffrè Switzerland 11 257 1.0× 279 1.0× 280 1.6× 136 1.1× 154 1.9× 15 775

Countries citing papers authored by Trish K. Lankford

Since Specialization
Citations

This map shows the geographic impact of Trish K. Lankford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trish K. Lankford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trish K. Lankford more than expected).

Fields of papers citing papers by Trish K. Lankford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trish K. Lankford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trish K. Lankford. The network helps show where Trish K. Lankford may publish in the future.

Co-authorship network of co-authors of Trish K. Lankford

This figure shows the co-authorship network connecting the top 25 collaborators of Trish K. Lankford. A scholar is included among the top collaborators of Trish K. Lankford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trish K. Lankford. Trish K. Lankford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Davern, Sandra, et al.. (2005). Identification of an Antilaminin-1 scFv That Preferentially Homes to Vascular Solid Tumors. Cancer Biotherapy and Radiopharmaceuticals. 20(5). 524–533. 4 indexed citations
2.
Kennel, Stephen J., et al.. (2005). Biodistribution of 225Ra citrate in mice: retention of daughter radioisotopes in bone. Nuclear Medicine and Biology. 32(8). 859–867. 9 indexed citations
3.
Hurst, Gregory B., Trish K. Lankford, & Stephen J. Kennel. (2004). Mass spectrometric detection of affinity purified crosslinked presented. Journal of the American Society for Mass Spectrometry. 15(6). 832–839. 54 indexed citations
4.
Foote, Linda J., et al.. (2004). A diabody that dissociates to monomer forms at low concentration: effects on binding activity and tumor targeting. Biochemical and Biophysical Research Communications. 327(4). 999–1005. 17 indexed citations
5.
Kennel, Stephen J., et al.. (2004). Phage Display Selection of scFv to Murine Endothelial Cell Membranes. PubMed. 23(4). 205–211. 7 indexed citations
6.
Jamasbi, Roudabeh J., Gary D. Stoner, Linda J. Foote, et al.. (2003). A Monoclonal Antibody to a Carbohydrate Epitope Expressed on Glycolipid and on α 3 β 1 Integrin on Human Esophageal Carcinoma. PubMed. 22(6). 367–376. 4 indexed citations
7.
Lankford, Trish K., Sandra Davern, Linda J. Foote, et al.. (2002). Therapy of rat tracheal carcinoma IC-12 in SCID mice. European Journal of Cancer. 38(9). 1278–1287. 13 indexed citations
8.
Kennel, Stephen J., Lara L. Chappell, Martin W. Brechbiel, et al.. (2000). Evaluation of 225 Ac for Vascular Targeted Radioimmunotherapy of Lung Tumors. Cancer Biotherapy and Radiopharmaceuticals. 15(3). 235–244. 69 indexed citations
9.
Kennel, Stephen J., Saed Mirzadeh, Gregory B. Hurst, et al.. (2000). Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors. Nuclear Medicine and Biology. 27(8). 815–825. 22 indexed citations
10.
Kennel, Stephen J., Trish K. Lankford, Linda J. Foote, et al.. (1999). Combination Vascular Targeted and Tumor Targeted Radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals. 14(5). 371–379. 6 indexed citations
11.
Kennel, Stephen J., Trish K. Lankford, Linda J. Foote, S G Shinpock, & Claude D. Stringer. (1993). CD44 expression on murine tissues. Journal of Cell Science. 104(2). 373–382. 81 indexed citations
12.
Kennel, Stephen J., et al.. (1992). The β4 subunit of the integrin family is displayed on a restricted subset of endothelium in mice. Journal of Cell Science. 101(1). 145–150. 70 indexed citations
13.
Kennel, Stephen J., Trish K. Lankford, Linda J. Foote, et al.. (1990). Second Generation Monoclonal Antibodies to the Human Integrin α 6 β 4. Hybridoma. 9(3). 243–255. 60 indexed citations
14.
Kennel, Stephen J., Trish K. Lankford, Pamela G. Galloway, & H.P. Witschi. (1989). A new monoclonal antibody to study mouse macrophage antigen during BHT-induced lung injury and repair. Toxicology. 55(1-2). 103–116. 7 indexed citations
15.
Kennel, Stephen J., Trish K. Lankford, Robert L. Ullrich, & Roudabeh J. Jamasbi. (1988). Enhancement of lung tumor colony formation by treatment of mice with monoclonal antibodies to pulmonary capillary endothelial cells.. PubMed. 48(17). 4964–8. 14 indexed citations
16.
Lankford, Trish K., et al.. (1988). Quantitation of a murine lung endothelial cell protein, P112, with a double monoclonal antibody assay.. Laboratory Investigation. 59(5). 692–701. 49 indexed citations
17.
Kennel, Stephen J., et al.. (1984). Monoclonal Antibodies in Cancer Detection and Therapy. BioScience. 34(3). 150–156. 82 indexed citations
18.
Kennel, Stephen J., Trish K. Lankford, & K. M. Flynn. (1983). Therapy of a murine sarcoma using syngeneic monoclonal antibody.. PubMed. 43(6). 2843–8. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michela Silacci Breakdown of academic impact, for papers by Timothy J. Dudgeon Breakdown of academic impact, for papers by Marlene Tacke Breakdown of academic impact, for papers by Ignacio Gonzales-Gomez Breakdown of academic impact, for papers by Alexander Zheleznyak Breakdown of academic impact, for papers by Thomas Schürpf Breakdown of academic impact, for papers by Steven J. Lahr Breakdown of academic impact, for papers by Jascha‐N. Rybak Breakdown of academic impact, for papers by Eckart Planker Breakdown of academic impact, for papers by Laura Giuffrè
Rankless by CCL
2026